Harshita Akkaraju

Harshita Akkaraju is currently a Senior Chemist in BioProduct R&D - Analytical Development at Eli Lilly and Company, a position held since July 2025. Prior to this role, Harshita worked as a Research Associate II in Analytical Development at ReCode Therapeutics from June 2023 to July 2025, where responsibilities included developing and qualifying an IP-RPLC method for analyzing mRNA 5' Cap structures and evaluating the purity of sgRNAs. Harshita gained foundational experience as an intern at Sandoz India Pvt Ltd in December 2019, focusing on Quality Control and HSE protocols. Harshita earned a Master of Science in Pharmaceutical Sciences with a Pharmaceutics track from the University of Pittsburgh in May 2023 and a Bachelor of Pharmacy from Manipal Academy of Higher Education in June 2021.